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GENERAL COMMENTS
This is a very clear and comprehensive manuscript. The methods are very well described and the goals made very clear. Quite remarkable undertaking. There are a few places where the grammar is a bit off or a word is missing but this should get picked up in the editing phase. I have no comments for review. 
REVIEWER

GENERAL COMMENTS
This study addresses the extent to which traditional Chinese medicine trials registered their trials prospectively and with complete registry entries. This is an important study that highlights the need for oversight of research to prevent publication bias.
--The primary outcome of the study and secondary outcomes are not clearly described--particularly in the abstract.
--It appears that almost half of the trials were uncompleted when evaluating their recruitment status (most trials were more recent between 2015-2017). Was this taken into account when you report that so many registry entries were missing data? --In the discussion, authors talk about the need for legislation to enforce these requirements. Is there any existing legislation in Hong Kong/China currently? What other non-US laws are there for examples?
--I would be careful about the suggestion to add other fields to the required list--I believe we should make this process streamlined and centralized to encourage better compliance. Enforcement of existing policies is key, and it seems things are improving with time.
VERSION 1 -AUTHOR RESPONSE
Reviewer(s)' Comments:
Reviewer: 1 1. The paper is well written. It would be useful to include pragmatic trials and CM diagnosis.
Response: Thanks to the reviewer's comments. This study included pragmatic trials and CM diagnosis, and the specific numbers were presented in Table 1 , (the column of type of study) and Table 6 (item 14).
Reviewer: 2 1. This is a very clear and comprehensive manuscript. The methods are very well described and the goals made very clear. Quite remarkable undertaking. There are a few places where the grammar is a bit off or a word is missing but this should get picked up in the editing phase. I have no comments for review.
Response: Thank you for the kind words. We edited our manuscript for language spelling and usage, and modified several grammatical errors all over the manuscript very carefully.
Reviewer: 3 1. This study addresses the extent to which traditional Chinese medicine trials registered their trials prospectively and with complete registry entries. This is an important study that highlights the need for oversight of research to prevent publication bias. The primary outcome of the study and secondary outcomes are not clearly described--particularly in the abstract. Response: Thanks to the reviewer's comments. We modified the abstract, especially in Methods section, to better present the primary outcome (e.g. quality assessment of TCM trial registration) and secondary outcomes (e.g. baseline characteristics of TCM trial registration) of this study. For example, we emphasized the registration quality assessment as the primary outcome of the study by adding these key words to the title and objective in the abstract. Moreover, we reorganized some sentences in the methods section (e.g. The primary analysis was to assess the reporting quality of registered trials with TCM interventions, which based on …; Descriptive statistics were additionally used to analyze the baseline characteristics of TCM trial registrations.) to make this information easier to understand.
2. It appears that almost half of the trials were uncompleted when evaluating their recruitment status (most trials were more recent between 2015-2017). Was this taken into account when you report that so many registry entries were missing data? Response: Thanks for your points. We need to explain the issue of "missing data", which is attributed to the inadequate reporting of registration items, but not affected with recruitment status. For example, of 2,955 TCM interventional trials, when assessing the reporting quality of item 13 (Intervention), 1,455 trials (49.2%) lacked information on detailed description of TCM interventions, which including both of completed trials and uncompleted trials (Table 6 ). For the calculation of recruitment status (e.g. almost half of the trials were uncompleted), it was taken into account when descripted the information of registered trials with publications links. For example, of 428 trials which linked their resultant publications to the trial registration system, 300 (70.1%) were completed trials (Table 4) . Thus, the number of uncompleted trials is as one factor that might related to the publication sharing in the registration system, but it is not the reason of the insufficient and/or missing reporting of registered information records. Actually, clinical trials should be registered before enrollment of the first patient. Unfortunately, there were many retrospectively registrations (e.g. completed recruitment) in this retrospective study. This is also one problem of registration quality which discussed already in the manuscript (Discussion section).
3. In the discussion, authors talk about the need for legislation to enforce these requirements. 
GENERAL COMMENTS
Thank you for addressing my questions. This is a well written manuscript addressing a very important topic.
